''
search

Hexarelin

€15.00
No tax
  • intensive secretion of growth hormone in response to administration, the most powerful
  • among all GHRP;
  • improvement of skin condition;
  • regeneration of injuries (joints, ligaments and even tendons);
  • normalization of the immune system;
  • increased bone density;
  • cardiotropic effect;
  • protection of nervous tissue;
  • rejuvenating effect;
  • accelerating the utilization of fat reserves;
  • the growth of dry muscle tissue.
  • Thus, we have before us the most potent peptide from GHRP, at the same time, it is characterized by a faster development of tolerance compared to other ghrelin-like peptides, which requires cycles of 2-3 weeks followed by a change to another peptide.
Quantity

100% secure payments
  Security policy

100% secure payments

  Delivery policy

We guarantee 100% safe delivery

  Return policy

if you do not receive the product, it will be sent free of charge at our expense

Hexarelin is a synthesized peptide that penetrates into the blood and is a highly selective agonist of the ghrelin receptor and growth hormone, which has a powerful effect on the secretion of endogenous growth hormone. It is the most powerful stimulator of STH secretion among all the drugs of the GHRP family, and, like GHRP2, is able to normalize the lipid profile of the blood, promote fat burning, improve the condition of the heart, protect neurons and suppress inflammation.

Effects

  • intensive secretion of growth hormone in response to administration, the most powerful
  • among all GHRP;
  • improvement of skin condition;
  • regeneration of injuries (joints, ligaments and even tendons);
  • normalization of the immune system;
  • increased bone density;
  • cardiotropic effect;
  • protection of nervous tissue;
  • rejuvenating effect;
  • accelerating the utilization of fat reserves;
  • the growth of dry muscle tissue.
  • Thus, we have before us the most potent peptide from GHRP, at the same time, it is characterized by a faster development of tolerance compared to other ghrelin-like peptides, which requires cycles of 2-3 weeks followed by a change to another peptide.

Mechanism of action


This hexapeptide is synthesized from GHRP-6. These GR-releasing peptides do not have a sequence similar to ghrelin, but mimic ghrelin, acting as agonists (activators) of the ghrelin receptor. Similarly to pralmorelin (GHRP-2) and GHRP-6, it slightly and dose-dependent stimulates the release of prolactin, adrenocorticotropic hormone (ACTH) and cortisol in humans. Hexarelin does not affect plasma glucose levels, luteinizing hormone (LH), follicle stimulating hormone (FSH) or thyroid stimulating hormone (TSH).
Hexarelin activates a significant release of endogenous growth hormone than its own hormone-releasing growth hormone (GHRH) in humans, and exhibits synergistic effects on the release of GH in combination with GHRH (CJC-1295), which leads to a huge increase in plasma STH levels even at low doses of the peptide. Testosterone, its esters and ethinyl estradiol have been found to significantly enhance the GH-releasing effect of hexarelin in humans due to increased levels of steroid receptors. Partial and reversible tolerance to the GH-releasing effects of this product occurs in humans with prolonged administration (50-75% decrease in effectiveness over weeks and months), therefore, after two to three weeks of administration, it is advisable to replace it with GHRP-6 or GHRP-2. The peptide was studied in phase II clinical trials for the treatment of growth hormone deficiency and congestive heart failure (which indicates its powerful effect both in the release of growth hormone and in improving the condition of the myocardium). Users report a significant ability of the peptide to promote injury regeneration.

Data sheet

Active substance
Hexarelin
Concentration
2 mg
Package
1 vials
chat Comments (0)
No customer reviews for the moment.